GLP-1R as a potential link between diabetes and Alzheimer’s disease

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This analysis reveals GLP-1R impacts insulin signaling in diabetes and reduces amyloid-beta in Alzheimer’s disease, suggesting a critical connection.

GLP-1R is pivotal in regulating glycemic control, affecting insulin secretion and lowering blood glucose in diabetes.
In Alzheimer’s disease, GLP-1R mitigates pathological features by reducing amyloid-beta deposition and enhancing clearance.
Both diabetes and Alzheimer’s disease share disrupted insulin signaling pathways, highlighting their interconnectedness.
Future investigations should focus on GLP-1R's mechanisms and the potential of GLP-1R agonists for dual therapies.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

This analysis reveals GLP-1R impacts insulin signaling in diabetes and reduces amyloid-beta in Alzheimer’s disease, suggesting a critical connection.

GLP-1R is pivotal in regulating glycemic control, affecting insulin secretion and lowering blood glucose in diabetes.
In Alzheimer’s disease, GLP-1R mitigates pathological features by reducing amyloid-beta deposition and enhancing clearance.
Both diabetes and Alzheimer’s disease share disrupted insulin signaling pathways, highlighting their interconnectedness.
Future investigations should focus on GLP-1R's mechanisms and the potential of GLP-1R agonists for dual therapies.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark